112 related articles for article (PubMed ID: 1545855)
21. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA
Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
[TBL] [Abstract][Full Text] [Related]
22. Modeling Alzheimer's disease in transgenic mice.
Duff K
J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
[TBL] [Abstract][Full Text] [Related]
23. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
24. [Biological characteristics of amyloid precursor protein and Alzheimer's disease].
Fukatsu R; Tsuzuki K; Takamaru Y; Hayashi Y; Sasaki N; Yoshida T; Midorikawa Y; Fujii N; Takahata N
Rinsho Byori; 1996 Mar; 44(3):213-24. PubMed ID: 8857163
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease. Short precursor shortens memory.
Mattson MP; Furukawa K
Nature; 1997 May; 387(6632):457-8. PubMed ID: 9168104
[No Abstract] [Full Text] [Related]
26. Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels.
Köhler C; Ebert U; Baumann K; Schröder H
Neurobiol Dis; 2005 Nov; 20(2):528-40. PubMed ID: 15921918
[TBL] [Abstract][Full Text] [Related]
27. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
[TBL] [Abstract][Full Text] [Related]
28. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
[TBL] [Abstract][Full Text] [Related]
29. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
[TBL] [Abstract][Full Text] [Related]
30. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U
Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711
[TBL] [Abstract][Full Text] [Related]
31. Intracellular amyloid-beta in Alzheimer's disease.
LaFerla FM; Green KN; Oddo S
Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515
[TBL] [Abstract][Full Text] [Related]
32. Amyloid, dementia and Alzheimer's disease.
Hyman BT; Tanzi RE
Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):88-93. PubMed ID: 1623244
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.
Perry G; Richey PL; Siedlak SL; Smith MA; Mulvihill P; DeWitt DA; Barnett J; Greenberg BD; Kalaria RN
Am J Pathol; 1993 Dec; 143(6):1586-93. PubMed ID: 7504885
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of Alzheimer's disease and dementia.
Bugiani O
Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
[TBL] [Abstract][Full Text] [Related]
36. [Estrogen: regulation of amyloid-beta protein metabolism and attenuation of amyloid-beta protein neurotoxicity].
Zhang S; Yao T
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):197-201. PubMed ID: 14628462
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
[TBL] [Abstract][Full Text] [Related]
38. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
39. [Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia].
Shoji M; Hirai S
Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):164-8. PubMed ID: 8648890
[No Abstract] [Full Text] [Related]
40. [Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].
Buée L; Blum D; Bombois S; Buée-Scherrer V; Caillet-Boudin ML; Colin M; Deramecourt V; Dhaenens CM; Galas MC; Hamdane M; Humez S; Maurage CA; Pasquier F; Sablonnière B; Schraen-Maschke S; Sergeant N
Therapie; 2010; 65(5):401-7. PubMed ID: 21144474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]